首页> 外文期刊>Stem cells translational medicine. >Rescue of an In Vitro Neuron Phenotype Identified in Niemann-Pick Disease, Type C1 Induced Pluripotent Stem Cell-Derived Neurons by Modulating the WNT Pathway and Calcium Signaling
【24h】

Rescue of an In Vitro Neuron Phenotype Identified in Niemann-Pick Disease, Type C1 Induced Pluripotent Stem Cell-Derived Neurons by Modulating the WNT Pathway and Calcium Signaling

机译:通过调节WNT途径和钙信号传导,在Niemann-Pick病,C1型诱导多能干细胞衍生神经元中鉴定的体外神经元表型的抢救

获取原文
获取原文并翻译 | 示例
           

摘要

Niemann-Pick disease, type Cl (NPC1) is a familial disorder that has devastating consequences on postnatal development with multisystem pffects, including neurodegeneration. There is no Food and Drug Administration-approved treatment option for NPC1; however, several potentially therapeutic compounds have been identified in assays using yeast, rodent models, and NPC1 human fibroblasts. Although these discoveries were made in fibroblasts from NPC1 subjects and were in some instances validated in animal models of the disease, testing these drugs on a cell type more relevant for NPC1 neurological disease would greatly facilitate both study of the disease and identification of more relevant therapeutic compounds. Toward this goal, we have generated an induced pluripotent stem cell line from a subject homozygous for the most frequent NPC1 mutation (p.I1061T) and subsequently created a stable line of neural stem cells (NSCs). These NSCs were then used to create neurons as an appropriate disease model. NPC1 neurons display a premature cell death phenotype, and gene expression analysis of these cells suggests dysfunction of important signaling pathways, including calcium and WNT. The clear readout from these cells makes them ideal candidates for high-throughput screening and will be a valuable tool to better understand the development of NPC1 in neural cells, as well as to develop better therapeutic options for NPC1.
机译:Niemann-Pick疾病,C1型(NPC1)是一种家族性疾病,具有多系统效应,包括神经退行性变,对出生后发展具有毁灭性后果。 NPC1没有获得美国食品药品监督管理局批准的治疗方案;然而,在使用酵母,啮齿动物模型和NPC1人成纤维细胞的测定中已鉴定出几种潜在的治疗性化合物。尽管这些发现是从NPC1受试者的成纤维细胞中获得的,并且在某些情况下已在该疾病的动物模型中得到验证,但在与NPC1神经系统疾病更相关的细胞类型上测试这些药物将极大地促进疾病的研究和更相关的治疗方法的鉴定化合物。为了实现这个目标,我们从纯合子中产生了最常见的NPC1突变(p.I1061T),并从中产生了诱导性多能干细胞系,随后又创建了稳定的神经干细胞系(NSCs)。然后将这些NSC用于创建神经元,作为合适的疾病模型。 NPC1神经元表现出过早的细胞死亡表型,并且对这些细胞的基因表达分析表明重要的信号传导途径(包括钙和WNT)功能异常。这些细胞的清晰读数使其成为高通量筛选的理想候选者,并且将是更好地了解神经细胞中NPC1的发育以及为NPC1开发更好的治疗选择的有价值的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号